SHOUGUANG FUKANG PHARMACEUTICAL CO LTD

Overview

SHOUGUANG FUKANG PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering CLOZAPINE; ESOMEPRAZOLE MAGNESIUM DIHYDRATE; ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; LANSOPRAZOLE; METFORMIN HYDROCHLORIDE; OMEPRAZOLE.

API / Drug Master Files

SHOUGUANG FUKANG PHARMACEUTICAL CO LTD holds 11 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ESOMEPRAZOLE MAGNESIUM DIHYDRATEActive2017-07-15
• ESOMEPRAZOLE MAGNESIUM TRIHYDRATEActive2014-07-03
• OMEPRAZOLE MAGNESIUMActive2013-11-13
• PANTOPRAZOLE SODIUMActive2013-07-31
• LANSOPRAZOLEActive2012-03-02
• CLOZAPINEActive2011-08-03
• TRIMETHOPRIMActive2011-08-01
• SULFAMETHOXAZOLEActive2011-08-01
• OMEPRAZOLEActive2011-05-02
• METFORMIN HYDROCHLORIDEActive2009-10-27
• OMEPRAZOLEActive2009-06-19

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHOUGUANG FUKANG PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.